Gastrointestinal Assessment of Three Novel RS4

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

December 22, 2018

Conditions
Diet Modification
Interventions
OTHER

Resistant Starch Type 4 Supplementation

Ten participants will supplement their normal dietary intake with RS4 daily for four consecutive weeks, with each week the amount of RS4 provided being increased (10 g, 20 g, 35 g and 50 g/day).

OTHER

Resistant Starch Type 4 Supplementation

Ten participants will supplement their normal dietary intake with RS4 daily for four consecutive weeks, with each week the amount of RS4 provided being increased (10 g, 20 g, 35 g and 50 g/day).

OTHER

Resistant Starch Type 4 Supplementation

Ten participants will supplement their normal dietary intake with RS4 daily for four consecutive weeks, with each week the amount of RS4 provided being increased (10 g, 20 g, 35 g and 50 g/day).

OTHER

Digestible Starch Supplementation

Ten participants will supplement their normal dietary intake with digestible starch daily for four consecutive weeks, with each week the amount of starch provided being increased.

Trial Locations (1)

T6G 2E1

Alberta Diabetes Institute Clinical Research Unit, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT03255603 - Gastrointestinal Assessment of Three Novel RS4 | Biotech Hunter | Biotech Hunter